| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 6.548 | 9.452 | 9.926 | 13.581 | 12.807 | 11.633 | 27.025 | 34.990 | 36.360 | 36.825 |
| Total Income - EUR | 6.548 | 9.452 | 9.926 | 13.581 | 12.807 | 11.633 | 27.025 | 34.990 | 36.360 | 36.825 |
| Total Expenses - EUR | 600 | 1.204 | 103 | 2.069 | 5.827 | 5.656 | 10.936 | 11.554 | 11.952 | 15.042 |
| Gross Profit/Loss - EUR | 5.948 | 8.247 | 9.823 | 11.512 | 6.980 | 5.976 | 16.090 | 23.436 | 24.408 | 21.784 |
| Net Profit/Loss - EUR | 5.751 | 7.984 | 9.535 | 11.264 | 6.851 | 5.860 | 15.819 | 23.086 | 24.056 | 21.423 |
| Employees | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Pavi Transmed Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | 9.024 | 16.892 | 9.659 | 12.404 | 8.401 | 4.921 | 16.590 | 33.561 | 25.237 | 22.789 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 6.863 | 14.686 | 8.802 | 3.354 | 3.277 | 3.933 | 16.129 | 14.829 | 19.439 | 8.729 |
| Cash | 2.161 | 2.207 | 857 | 9.049 | 5.124 | 989 | 461 | 18.732 | 5.798 | 14.060 |
| Shareholders Funds | 8.835 | 16.729 | 9.579 | 11.307 | 6.893 | 7.413 | 17.337 | 40.476 | 24.096 | 21.463 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 189 | 163 | 80 | 1.097 | 1.508 | 609 | 2.689 | 2.534 | 1.141 | 1.326 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "7499 - 7499" | |||||||||
| CAEN Financial Year |
7490
|
|||||||||
Comments - Pavi Transmed Srl